KURLADIQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Aug 2024)
What this means for you
This application is over — abandoned 12 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97596535
- Mark type
- Stylized text
- Filed
- 19 Sept 2022
- Published for opposition
- 14 Nov 2023
- Abandoned
- 12 Aug 2024
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases and disorders
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of genetic diseases and disorders; medical and scientific research services in the field of genetic disease and disorder treatment
- Class 044 — Medical, beauty and agricultural services: Providing medical and health information in the field of genetic diseases and disorders; providing information in the field of genetic diseases and disorders treatment; Providing links to the web sites of others featuring medical and health information about genetic diseases and disorders; providing links to the web sites of others featuring information about the diagnosis and treatment of genetic diseases and disorders
Owner
- Rocket Pharmaceuticals, Inc., Cranbury, NJ, US
- Rocket Pharmaceuticals, Inc., Cranbury, NJ, US
Prosecution history
- 12 Aug 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Aug 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2023 — PUBLISHED FOR OPPOSITION
- 25 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jul 2023 — NON-FINAL ACTION E-MAILED
- 05 Jul 2023 — NON-FINAL ACTION WRITTEN
- 29 Jun 2023 — ASSIGNED TO EXAMINER
- 15 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED